Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Net Margin (2016 - 2025)

Historic Net Margin for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to 312.94%.

  • Jaguar Health's Net Margin rose 94800.0% to 312.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 348.22%, marking a year-over-year increase of 135000.0%. This contributed to the annual value of 329.3% for FY2024, which is 938100.0% up from last year.
  • As of Q3 2025, Jaguar Health's Net Margin stood at 312.94%, which was up 94800.0% from 354.48% recorded in Q2 2025.
  • Over the past 5 years, Jaguar Health's Net Margin peaked at 232.55% during Q4 2022, and registered a low of 3657.4% during Q2 2021.
  • For the 5-year period, Jaguar Health's Net Margin averaged around 691.25%, with its median value being 397.46% (2022).
  • Per our database at Business Quant, Jaguar Health's Net Margin tumbled by -33228000bps in 2021 and then surged by 33367200bps in 2022.
  • Over the past 5 years, Jaguar Health's Net Margin (Quarter) stood at 688.12% in 2021, then soared by 66bps to 232.55% in 2022, then plummeted by -71bps to 398.7% in 2023, then rose by 27bps to 291.65% in 2024, then fell by -7bps to 312.94% in 2025.
  • Its Net Margin stands at 312.94% for Q3 2025, versus 354.48% for Q2 2025 and 478.59% for Q1 2025.